STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Aug. 31, 2020

Equity [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive loss (in thousands):

	Three Months Ended				Six Months Ended
	August 31,				August 31,
	2020		2019		2020		2019
Cost of revenues	$	203	$	162	$	378	$	337
Research and development		723		633		1,369		1,046
Selling and marketing		760		982		1,265		1,651
General and administrative		1,160		1,406		2,582		2,692
Restructuring		-		-		875		-
	$	2,846	$	3,183	$	6,469	$	5,726

Summary of Stock Option Activity

Changes in our outstanding stock options during the six months ended August 31, 2020 were as follows (options in thousands):

	Number of Options			Weighted Average Exercise Price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at February 29, 2020		1,071		$	14.65		6.2
Granted		—			—
Exercised		(70	)		4.03
Forfeited or expired		(152	)		17.52
Outstanding at August 31, 2020		849		$	15.02		6.0	$	309
Exercisable at August 31, 2020		578		$	14.37		5.1	$	309

Summary of Restricted Stock Shares (RSU's), and Performance Stock Units (PSU's) Activity

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the six months ended August 31, 2020 were as follows (restricted shares, PSUs and RSUs in thousands):

	Number of Restricted Shares, PSUs and RSUs			Weighted Average Grant Date Fair Value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Outstanding at February 29, 2020		2,215		$	14.47
Granted		1,778			7.86
Vested		(611	)		14.97		199
Forfeited		(152	)		13.46
Outstanding at August 31, 2020		3,230		$	10.78